In the present prospective study, which encompasses 133 patients with neutropenia lasting more than two months, we assessed the value of using the plasma protein hCAP-18 (pro-LL-37), which is the proprotein of the antibacterial peptide LL-3718, as a marker to discriminate neutropenia of various aetiologies. This evidence concerns the gene CAMP and neutropenia.